Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New challenges in coronary stenting.

R A Schatz1

  • 1Scripps Memorial, La Jolla, California, USA.

The Journal of Invasive Cardiology
|December 9, 1994
PubMed
Summary
This summary is machine-generated.

Future coronary stenting with Palmaz-Schatz stents may improve safety and efficacy. Heparin coatings aim to reduce thrombosis, bleeding, and restenosis, offering cost-effective treatment for coronary artery and bypass graft disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of methionine on the uptake, distribution, and binding of the convulsant methionine sulfoximine in the rat.

Neurochemical research·2013
Same author

S-Adenosyl-L-homocysteine in brain : Regional concentrations, catabolism, and the effects of methionine sulfoximine.

Neurochemical research·2013
Same author

Early lumen loss after repeat coronary intervention for in-stent restenosis.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
Same author

Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials.

The American journal of cardiology·2000
Same author

Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial.

Circulation·2000
Same author

Effect of low-level short-term o-xylene inhalation of benzo[a]pyrene (BaP) metabolism and BaP-DNA adduct formation in rat liver and lung microsomes.

Journal of toxicology and environmental health. Part A·1999
Same journal

Sex differences in reverse remodeling after transcatheter aortic valve replacement in low-flow aortic stenosis.

The Journal of invasive cardiology·2026
Same journal

Coronary computed tomography angiography to guide percutaneous coronary intervention: proceedings from the 1st CCTA-guided PCI summit in the United States.

The Journal of invasive cardiology·2026
Same journal

When not to pull: radial srtery spasm, catheter entrapment, and the value of waiting.

The Journal of invasive cardiology·2026
Same journal

Severe coronary vasospasm mimicking STEMI after drug-coated balloon angioplasty.

The Journal of invasive cardiology·2026
Same journal

Imaging insights into endothelial response: cardiac computed tomography assessment of WATCHMAN FLX and FLX Pro.

The Journal of invasive cardiology·2026
Same journal

Differential effect of chronic kidney disease on right-sided extravalvular damage in low-flow, low-gradient aortic stenosis.

The Journal of invasive cardiology·2026
See all related articles

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Coronary stenting, particularly with the Palmaz-Schatz coronary stent, has seen significant advancements.
  • The evolution of stent technology aims to improve patient outcomes and procedural success.

Purpose of the Study:

  • To highlight the potential benefits of future Palmaz-Schatz coronary stent modifications.
  • To discuss the anticipated enhancements in safety and efficacy through custom length and heparin coating.

Main Methods:

  • Review of evolving coronary stenting technologies and materials.
  • Analysis of the projected impact of heparin coating and radiopaque features on stent performance.

Main Results:

Related Experiment Videos

  • Custom length and heparin-coated, more radiopaque Palmaz-Schatz stents are expected to improve safety and efficacy.
  • Heparin coating shows promise in reducing subacute stent thrombosis, vascular bleeding, and restenosis rates.

Conclusions:

  • The modified Palmaz-Schatz coronary stent holds potential as a cost-effective therapy for native coronary artery and saphenous vein bypass graft disease.
  • Further advancements in stent design and coatings are crucial for optimizing treatment of complex coronary artery disease.